-
Posted by
Two Blokes May 2 -
Filed in
Stock
-
0 views
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for the experimental once-daily oral version of its blockbuster weight-loss drug Wegovy, the Danish drugmaker said on Friday.